In order to further investigate whether MSC + Tβ4 combination therapy can alleviate DED damage by inhibiting GLS1, interventions targeting GLS1 overexpression and inhibition were conducted in an in vitro dry eye model (Fig. 5a). Here, GLS is linked to dry eye syndrome.